Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
300 participants
INTERVENTIONAL
2020-01-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tai Chi (5 times/week)
5 sessions of Tai Chi per week for 12 weeks
Tai Chi
24-form Tai Chi will be performed for 12 weeks. Each session contains a warm-up period (10 minutes), a Tai Chi period (40 minutes) and a cool-down period (10 minutes).
Tai Chi (3 times/week)
3 sessions of Tai Chi per week for 12 weeks
Tai Chi
24-form Tai Chi will be performed for 12 weeks. Each session contains a warm-up period (10 minutes), a Tai Chi period (40 minutes) and a cool-down period (10 minutes).
Tai Chi (1 time/week)
1 session of Tai Chi per week for 12 weeks
Tai Chi
24-form Tai Chi will be performed for 12 weeks. Each session contains a warm-up period (10 minutes), a Tai Chi period (40 minutes) and a cool-down period (10 minutes).
cognitive behavior therapy (CBT)
1 session of CBT per week for 12 weeks
CBT
CBT will be performed once a week for 12 weeks. Each session lasts for 1 hour.
Waiting-list
Participants will maintain their routine treatment and life style for 12 weeks.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tai Chi
24-form Tai Chi will be performed for 12 weeks. Each session contains a warm-up period (10 minutes), a Tai Chi period (40 minutes) and a cool-down period (10 minutes).
CBT
CBT will be performed once a week for 12 weeks. Each session lasts for 1 hour.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants diagnosed with T2DM by experienced endocrinologist;
* Participants aged between 18\~75 years;
* Participants with HbA1c ranges from 6.5% to 8.5%;
* Participants with Hamilton Depression Scale (HAMD) (24-item-version) ranges from 20\~35 scores;
* Participants passed the Physical Activity Readiness Questionnaire (PAR-Q);
* Participants willing to complete 12-week intervention and 12-week follow-up.
* Participants willing to sign informed consent form.
Exclusion Criteria
* Participants with severe diabetic complications;
* Regular exercisers (at least 20 minutes/time, 3 times/week) in the last 3 months;
* Participants with cognitive impairment (Montreal Cognitive Assessment \[MoCA\] scores \<26);
* Participants with history of bipolar disorder or schizophrenia or other mental illness;
* Participants with contraindications to exercise;
* Participants with acute, infectious diseases, cancer, or serious neurological disease, cardiovascular disease, pulmonary disease or other serious medical conditions limiting the ability;
* Participants taking psychoactive drugs;
* Participants participating in other clinical trials at the same time.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Electronic Science and Technology of China
OTHER
Chengdu University of Traditional Chinese Medicine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Di Qin
Chengdu University of Traditional Chinese Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Youping Liu, PhD
Role: STUDY_CHAIR
Chengdu University of Traditional Chinese Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Heilongjiang University of Chinese Medicine
Harbin, Heilongjiang, China
Henan University of Chinese Medicine
Zhengzhou, Henan, China
Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (Sichuan Provincial Hospital of Traditional Chinese Medicine)
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019YFC1710302
Identifier Type: -
Identifier Source: org_study_id